BCR-signalling Synergizes with TLR-signalling for Induction of AID and Immunoglobulin Class-switching Through the Non-canonical NF-κB Pathway
Overview
Authors
Affiliations
By diversifying antibody biological effector functions, class switch DNA recombination has a central role in the maturation of the antibody response. Here we show that BCR-signalling synergizes with Toll-like receptor (TLR) signalling to induce class switch DNA recombination. BCR-signalling activates the non-canonical NF-κB pathway and enhances the TLR-dependent canonical NF-κB pathway, thereby inducing activation-induced cytidine deaminase (AID), which is critical for class switch DNA recombination. Escherichia coli lipopolysaccharide (LPS) triggers dual TLR4/BCR-signalling and induces hallmarks of BCR-signalling, including CD79a phosphorylation and Ca(2+) mobilization, and activates both the NF-κB pathways to induce AID and class switch DNA recombination in a PI(3)K p85α-dependent fashion. CD40-signalling activates the two NF-κB pathways to induce AID and class switch DNA recombination independent of BCR-signalling. Finally, dual BCR/TLR-engaging NP-lipopolysaccharide effectively elicits class-switched NP-specific IgG3 and IgG2b in mice. Thus, by integrating signals of the non-canonical and canonical NF-κB pathways, BCR and TLRs synergize to induce AID and T-cell-independent class switch DNA recombination.
Decoy oligonucleotides targeting NF-κB: a promising therapeutic approach for inflammatory diseases.
Mahjoubin-Tehran M, Rezaei S, Butler A, Sahebkar A Inflamm Res. 2025; 74(1):47.
PMID: 40047902 DOI: 10.1007/s00011-025-02021-8.
Roy K, Vareli A, Mitchell S Methods Mol Biol. 2025; 2909:165-178.
PMID: 40029522 DOI: 10.1007/978-1-0716-4442-3_12.
Gut IgA functionally interacts with systemic IgG to enhance antipneumococcal vaccine responses.
Gutzeit C, Grasset E, Matthews D, Maglione P, Britton G, Miller H Sci Adv. 2025; 11(7):eado9455.
PMID: 39937896 PMC: 11817949. DOI: 10.1126/sciadv.ado9455.
Lipid Antigens: Revealing the Hidden Players in Adaptive Immune Responses.
Eskandari T, Eivazzadeh Y, Khaleghinia F, Kashi F, Oksenych V, Haghmorad D Biomolecules. 2025; 15(1).
PMID: 39858478 PMC: 11763959. DOI: 10.3390/biom15010084.
Sobczynska-Konefal A, Jasek M, Karabon L, Jaskula E Biomark Res. 2024; 12(1):162.
PMID: 39732734 PMC: 11682641. DOI: 10.1186/s40364-024-00710-w.